Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Junshik | - |
dc.contributor.author | Park, Sanghui | - |
dc.contributor.author | Baek, Hae Lim | - |
dc.contributor.author | Jung, Joo Hyun | - |
dc.contributor.author | Kang, Il Gyu | - |
dc.contributor.author | Sym, Sun Jin | - |
dc.contributor.author | Park, Jinny | - |
dc.contributor.author | Ahn, Jeong Yeal | - |
dc.contributor.author | Cho, Eun Kyung | - |
dc.contributor.author | Kim, Seon Tae | - |
dc.contributor.author | Shin, Dong Bok | - |
dc.contributor.author | Lee, Jae Hoon | - |
dc.date.available | 2020-02-29T09:47:56Z | - |
dc.date.created | 2020-02-05 | - |
dc.date.issued | 2012-10 | - |
dc.identifier.issn | 1936-2625 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/17582 | - |
dc.description.abstract | Extranodal natural killer/T-cell lymphoma, nasal type (nasal ENKTL) is a distinct clinicopathologic entity of lymphoid tumors with variable size and differentiation of tumor cells. Nasal ENKTL is related to infection of the tumor cells with Epstein-Barr virus (EBV) and virtually all cases contain monoclonal episomal EBV DNA and detectable EBV encoded small nuclear RNAs (EBERs). Several clinical factors are known for their relation to the prognosis, but histopathologic prognostic factors of nasal ENKTL have not yet been well established. We evaluated the prognostic value of the longest nuclear diameter of EBER+ tumor cells (NDTC) along with the result of CD30 expression. Twenty two patients with newly diagnosed nasal ENKTL were evaluated regarding clinicopathologic characteristics. NDTC was measured using a computerized image analysis system. The results were expressed as the mean diameter of >= 50 cells in a patient. Median of the mean NDTC of the patients was 7.32 mu m (5.15-11.27). Patients with larger mean NDTC (>= 7.35 mu m) had a poorer event-free survival (EFS) than those with smaller mean NDTC (< 7.35 mu m; p = 0.024) and had a tendency of inferior overall survival (OS) (p = 0.08). Patients with CD30 expression had a inferior EFS (p = 0.018) and OS (p = 0.011) compared those without CD30 expression. The NDTC of EBV infected tumor cell and CD30 expression had relation to survival in the current exploratory analysis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | E-CENTURY PUBLISHING CORP | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | - |
dc.title | Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000310832200010 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, v.5, no.9, pp.939 - 947 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84870414340 | - |
dc.citation.endPage | 947 | - |
dc.citation.startPage | 939 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | - |
dc.citation.volume | 5 | - |
dc.citation.number | 9 | - |
dc.contributor.affiliatedAuthor | Hong, Junshik | - |
dc.contributor.affiliatedAuthor | Baek, Hae Lim | - |
dc.contributor.affiliatedAuthor | Jung, Joo Hyun | - |
dc.contributor.affiliatedAuthor | Kang, Il Gyu | - |
dc.contributor.affiliatedAuthor | Sym, Sun Jin | - |
dc.contributor.affiliatedAuthor | Park, Jinny | - |
dc.contributor.affiliatedAuthor | Ahn, Jeong Yeal | - |
dc.contributor.affiliatedAuthor | Cho, Eun Kyung | - |
dc.contributor.affiliatedAuthor | Kim, Seon Tae | - |
dc.contributor.affiliatedAuthor | Shin, Dong Bok | - |
dc.contributor.affiliatedAuthor | Lee, Jae Hoon | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Extranodal NK/T-cell lymphoma | - |
dc.subject.keywordAuthor | nasal type | - |
dc.subject.keywordAuthor | epstein-barr virus | - |
dc.subject.keywordAuthor | CD30 | - |
dc.subject.keywordAuthor | prognosis | - |
dc.subject.keywordAuthor | nuclear diameter | - |
dc.subject.keywordPlus | T-CELL | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | MUTATIONS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | TAIWAN | - |
dc.subject.keywordPlus | HEALTH | - |
dc.subject.keywordPlus | JAPAN | - |
dc.subject.keywordPlus | P53 | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Pathology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Pathology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.